The Role of Long-Acting Formulations in the GHD Market   The Growth Hormone Deficiency Market is being revolutionized by the introduction of long-acting growth hormone formulations, which are poised to transform the landscape of patient care. Historically, the standard treatment for GHD has involved daily subcutaneous injections of recombinant human growth hormone (rhGH), a regimen that...